Introduction
Most children with epilepsy do well on antiepileptic treatment. However, some patients respond poorly to antiepileptic drugs (AEDs) and develop refractory (intractable) epilepsy. Early identification of children at risk of developing refractory epilepsy is important for parents' counselling and consideration of alternative treatments. Some studies investigating prognostic factors of refractory epilepsy have been published, but most of them have a case-control design. [1] [2] [3] [4] [5] [6] [7] [8] [9] This type of study does not allow estimation of the risk of developing refractory epilepsy in patients with a given risk factor. Only three prospective cohort studies are available. 2, 7, 9 One of them did not include patients younger than 2 years old 7 , a group of children particularly at risk of developing refractory epilepsy, and the other one used broad criteria for defining refractory epilepsy. 9 Therefore, a prospective cohort study is needed. The objective of the present work is to investigate the value of potential prognostic factors identifiable at 6 months from diagnosis in a prospectively followed cohort of children younger than 14 years old with recent-onset epilepsy.
Methods

Definitions and classification criteria
Seizures were considered unprovoked when they occurred in the absence of any known proximate precipitant. More than one seizure within a period of 24 h was considered to be a single seizure (multiple seizure). Epilepsy was defined as the occurrence of two or more unprovoked seizures. Status epilepticus was defined as a seizure lasting more than 30 min or recurrent seizures lasting a total of more than 30 min without the patient fully regaining consciousness. The type of seizure was classified according to the 1981 ILAE criteria. 10 We considered that a patient had various seizure types when he/she had both partial and generalized seizures, various types of partial seizures (for example simple partial and secondarily generalized seizures) or various types of generalized seizures (for example absences and generalized tonicclonic seizures). Epilepsies were classified according to their aetiology as idiopathic, cryptogenic or remote symptomatic, following the ILAE criteria. 11 In particular, epilepsies were classified as remote symptomatic when they occurred in a patient with a history of a static encephalopathy of pre-or perinatal origin or a prior neurological insult such as central nervous system infection, stroke or significant head trauma. 11 Classification of patients by epileptic syndrome was also performed according to the ILAE revised 1989 classification. 12 Into the category ''without unequivocal partial or generalized seizures'' we classified all patients with apparently generalized tonic-clonic seizures and a normal EEG. Two new syndromes, not included in this classification, were also diagnosed: benign infantile seizures and earlyonset benign childhood occipital epilepsy (Panayiotopoulos type). EEGs were classified as normal or abnormal; the latter category includes both epileptiform (focal or generalized spike-waves) and nonepileptiform (focal or generalized slowing) abnormalities. A family history of unprovoked seizures was defined as seizures occurring in a first-degree relative (parent or sibling). Neuroimaging was classified as abnormal only when the observed abnormality was considered the cause of epilepsy. Global developmental delay was defined as a developmental quotient below 70% and mental retardation as an intelligence quotient below 70. When formal intelligence tests were not available, intelligence was clinically assessed. Motor deficit was considered as present if there was hemiplegia, quadriplegia or diplegia. Refractory epilepsy was defined as failure, due to lack of seizure control, of more than 2 AED at maximum tolerated doses, with an average of more than 1 seizure per month for !18 months and no more than 3 consecutive months seizure-free during this interval. 2 Drugs withdrawn due to intolerable adverse effects in patients without recurrences were not taken into account.
Cohort selection
Torrecá rdenas Hospital is the reference hospital of the province of Almería (Spain). The only EEG laboratory and paediatric neurology unit in the province are located in this hospital. Between June 1, 1994 and December 31, 2004 all patients aged less than 14 years who were consecutively seen at our institution for two or more unprovoked seizures were enrolled in a prospective study. Patients with seizures limited to the neonatal period, inborn errors of metabolism, neurodegenerative disorders, children already on antiepileptic treatment and those who had previously been examined in other centres were excluded. Consequently, all patients were directly referred by primary care paediatricians or were first seen in the emergency department of our hospital. The study was approved by the ethical committee of the hospital and informed consent was obtained to participate in it.
Initial evaluation
For every patient, family and medical history were taken, a physical and neurological examination was performed and a standard EEG was obtained at diagnosis of epilepsy. When the standard EEG was normal, a sleep record was performed.
Computed tomography or magnetic resonance imaging was performed at least in the cases with abnormal findings in the neurological examination, partial seizures, focal abnormalities on the EEG (except in the case of benign childhood epilepsy with centro-temporal spikes) or West syndrome.
Follow-up
All patients were followed through personal interviews at regular intervals until December 31, 2006 (to allow for a minimum of 2 years' follow-up) or until they attain a remission of 3 years without AEDs (i.e. 3 years without either relapses or treatment). Patients in remission were thereafter contacted by telephone until a follow-up of 5 years without antiepileptic treatment was completed. Then, patients were instructed to contact us if a relapse occurred. Otherwise the patient was considered in remission.
Predictors of refractoriness
The following variables, all measured at 6 months of follow-up, were explored: sex, age at onset of epilepsy in years, prior febrile seizures, prior neonatal seizures, family history of epilepsy in firstdegree relatives, aetiology, global developmental delay/mental retardation, motor deficit, abnormal neuroimaging (compared to normal or not done), status epilepticus at diagnosis, multiple seizures at diagnosis, abnormal EEG, various seizures types, West syndrome, number of seizures before diagnosis and number of seizures during the first 6 months after diagnosis. For treated patients the date of diagnosis was the same as the date of treatment onset. For patients with epilepsies characterised by a high frequency of seizures, such as absence epilepsy or West syndrome, seizures during the initial medication titration phase were not considered as recurrences.
Analysis
Risk of developing refractory epilepsy was calculated using Kaplan-Meier survival curves. Patients entered the study on the date of diagnosis of epilepsy. The event under study was fulfilling the criteria of refractory epilepsy. Cases were considered censored if, at the end of the study, the event under observation had not occurred or if contact with the patient was lost. We carried out univariable and multivariable analyses of potential predictors of developing refractory epilepsy using Cox proportional hazards model. Calculations were performed by means of statistical software SPSS for Windows, version 15.0. The level of statistical significance was established at p < 0.05.
Results
General features of the sample
Three hundred and fifty-three children were enrolled in the study. 8 patients were lost to follow-up before completing a minimum follow-up period of 2 years and 2 children died within 2 years of diagnosis. Therefore, 343 patients were followed-up for more than 2 years and they constitute the sample of this study. Thereafter, another 6 patients were lost to follow-up and 4 children died. Overall, we lost contact with only 4% (8 + 6) cases from the initial sample. Mean age at diagnosis was 4.8 (AE3.8 SD) years. 68 (20%) of the children were younger than 1 year of age at diagnosis of epilepsy, 236 (69%) between 1 and 9 years old and 39 (11%) were 10 years of age or older. 191 (56%) were male and 152 (44%) female. 34 (9.9%) patients were not treated. Mean follow-up period was 76.2 (AE35.2 SD) months (range 24-139). Of the 343 children, 249 (73%) were followed for more than 4 years, 168 (49%) for more than 6 years and 104 (30%) for more than 8 years.
Overall risk of developing refractory epilepsy
Thirty out of 343 patients (8.7%) met the criteria of refractory epilepsy. The Kaplan-Meier estimate of the risk of developing refractory epilepsy was 5% (95% CI: 3-7), 7% (95% CI: 4-10), 8% (95% CI: 5-11), 11% (95% CI: 7-15) and 12% (95% CI: 7-17) at 2, 4, 6, 8, and 10 years respectively.
Epileptic syndromes
The risk of developing refractory epilepsy was higher in West syndrome and in symptomatic generalized and symptomatic partial groups, it was lower in idiopathic partial and idiopathic generalized groups and it was intermediate in cryptogenic partial and in epilepsies without unequivocal focal or generalized seizures (Table 1) .
Predictors of refractory epilepsy
Risk of developing refractory epilepsy was very low in idiopathic epilepsy, it was high in remote symptomatic epilepsy and it was intermediate in cryptogenic epilepsy. Risk of developing refractory epilepsy at 2, 6 and 10 years was 1% (95% CI: 0-2), 2% (95% CI: 0-2) and 2% (95% CI: 0-2) for idiopathic epilepsy, 3% (95% CI: 0-7), 9% (95% CI: 2-16) and 9% (95% CI: 2-16) for cryptogenic epilepsy, and 11% (95% CI: 5-17), 16% (95% CI: 9-23), and 28% (95% CI: 16-40) for remote symptomatic epilepsy.
In univariable analysis, age at onset of epilepsy under 1 year, remote symptomatic aetiology, global developmental delay/ mental retardation, abnormal neuroimaging, a multiple first seizure, West syndrome, more than one recurrence during the first 6 months after diagnosis and more than five seizures before diagnosis, were all significant predictors of a higher risk of developing refractory epilepsy. Conversely, idiopathic aetiology was a significant predictor of a lower risk (Table 2) .
In multivariable analysis with complete variable set, idiopathic aetiology remained a significant predictor of a lower risk of developing refractory epilepsy and more than one recurrence during the first 6 months after diagnosis remained a significant predictor of a higher risk. Age at onset of epilepsy was almost significant (Table 2) .
For more clinically relevant data, Table 3 shows the observed risk of developing refractory epilepsy for patients with the three more powerful predictive factors in multivariable analysis and Table 4 shows the risk for patients with various combinations of these factors.
Discussion
Prospective studies in children and adults with recent-onset epilepsy have found a probability of achieving a 2-year initial remission of 80-90% at 5-9 years. [13] [14] [15] [16] [17] [18] However, some patients cannot be controlled adequately with antiepileptic medication and develop refractory (intractable) epilepsy. The definition of refractory epilepsy varies in different studies. Those studies on children using stringent criteria, similar to those used in our study, have found an incidence of refractory epilepsy between 6% and 14%. 1, 2, 19, 20 Early identification of children at risk of developing refractory epilepsy is important for parents' counselling and consideration of alternative treatments.
A number of studies investigating predictive factors for refractory epilepsy in children were published. Most of these studies used stringent definitions of refractory epilepsy, similar to the one used in our study. [1] [2] [3] [4] [5] [6] [7] Two studies included less severe cases. 8, 9 Most of these studies have a case-control design. This type of study does not allow estimation of the risk of developing refractory epilepsy in patients with a given risk factor. Only three prospective cohort studies are available. 2, 7, 9 One of them did not include patients younger than 2 years old 7 (as discussed below, a group of children particularly at risk of developing refractory epilepsy). Therefore, there was a need for a population-based prospective cohort study. Although our study is hospital-based, it has been designed to obtain a sample as representative of general population as possible. Most patients in Almería with epileptic seizures are cared for in Torrecardenas Hospital since it has the only paediatric neurology unit in the province. Patients previously examined in other centres were excluded. Consequently, our sample is based exclusively on direct referrals by primary care paediatricians and patients first seen at the emergency department of our hospital. The features of our sample are in accordance with those found in epidemiological population-based studies of epilepsy. [21] [22] [23] We have focused on early predictors of refractory epilepsy and we have studied the prognostic value of those present within 6 months after diagnosis of epilepsy. The two factors more consistently linked to the risk of refractory epilepsy in previous studies have been the aetiology and the age at onset of epilepsy. In all the aforementioned studies, aetiology was a strong prognostic factor. [1] [2] [3] [4] [5] [6] [7] [8] [9] All but one, which did not include children younger than 2 years old 7 , found a higher risk of refractory epilepsy in children with remote symptomatic epilepsy. Six out of six studies found a higher risk related to the presence of mental retardation and/or motor deficit [3] [4] [5] [6] [7] 9 and three out of three, a worse prognosis in children with abnormal neuroimaging. 2, 5, 6 In our univariable analysis, remote symptomatic aetiology, global developmental delay/mental retardation and abnormal neuroimaging, significantly increased the risk of developing refractory epilepsy. The presence of motor deficit showed a non-significant trend towards a higher risk. Conversely, idiopathic aetiology was a significant predictor of a lower risk of refractory epilepsy. However, in multivariable analysis, idiopathic aetiology was the only independent predictor of refractory epilepsy among those related to aetiology. The risk of developing refractory epilepsy at 6 years was 2% (95% CI: 0-2) in idiopathic epilepsy compared to 13% (95% CI: 9-18) in non-idiopathic epilepsy.
The second factor strongly correlated in the literature with the risk of developing refractoriness is the age at onset of epilepsy. All but two of the previous studies 7,9 found a greater risk of refractory epilepsy in younger children, particularly in those younger than 1 year old. In one of these two studies, only patients older than two were enrolled. 7 The association remained in multivariable analysis in most of these studies. In our study, children aged under 1 at the onset of epilepsy showed a significant association with a greater risk of refractory epilepsy in univariable analysis and an almost significant tendency towards a greater risk in multivariable analysis. Risk of refractory epilepsy at 6 years was 20% (95% CI: 10-30) in children younger than 1 compared with 5% (95% CI: 2-8) in older children. Three out of three studies found a higher risk of refractory epilepsy in patients with recurrences after beginning antiepileptic treatment, although the variables measured were different: a high initial frequency of seizures 9 , three or more seizures in the second 6 months of treatment 6 and seizure recurrence in the interval from sixth to twelfth months after initiating therapy. 7 In a previous study carried out by our group, which involved a different sample, recurrence of seizures in the first 6 months of treatment diminished the probability of achieving a 2-year initial remission and a 3-year terminal remission without treatment. 17, 24 In our new study, the risk of developing refractory epilepsy was 19% (95% CI: 12-26) at 6 years in children with more than one recurrence in the first 6 months after diagnosis compared to 2% (95% CI: 0-4) in those with only one or no recurrences. This association was significant in univariable and multivariable analyses.
In the present study, a simple model comprising three variables (aetiology, age at onset of epilepsy and number of seizures during the first 6 months after diagnosis) classified epileptic patients in groups with low, intermediate and high risk of refractory epilepsy.
The value of other potential predictive factors is less established. Five out of six previous studies found, in univariable analysis, a higher risk of refractory epilepsy in patients with West syndrome or infantile spasms. 1, 4, 6, 9 In two, the association remained in multivariable analysis. 1, 4 Similarly, in our study the association was significant in the univariable but not in the multivariable analysis. Some authors 2, 3, 6 but not all 7,9 found a greater risk of refractory epilepsy in patients with a high number of pre-treatment seizures. In none of these studies the association was significant in multivariable analysis. In our study, this factor was significant only in univariable analysis, although there was also a clear trend in multivariable analysis. A significant proportion of studies available observed a greater risk of refractory epilepsy in patients with prior neonatal seizures 1,2,4,6,8 but only in univariable analysis. In our cohort, we observed a clear but non-significant tendency towards a higher risk of refractory epilepsy in this situation, but we found it only in univariable analysis. A history of status epilepticus has also been frequently associated with a worse prognosis. [1] [2] [3] 5, 6, 8, 9 This was not observed in our sample. Nevertheless, we have found a greater risk of refractory epilepsy in patients with a multiple first seizure, but solely in univariable analysis. One previous study has investigated this question and made similar findings.
2
The findings about the predictive value of the EEG are discordant, regarding whether there is an association or not and in relation to the type of abnormality with prognostic value. 2, 3, [5] [6] [7] [8] We have found no relationship between an abnormal EEG during the first 6 months after diagnosis and the risk of refractory epilepsy.
Finally, we have not found any predictive value for the presence of prior febrile seizures. Only one out of nine previous studies found a significant relationship between this factor and the risk of refractoriness. Table 3 Risk of developing refractory epilepsy as a function of aetiology, age at onset of epilepsy and number of seizures during the first 6 months after diagnosis. Kaplan-Meier estimates. Regarding the predictive value of syndromic diagnosis, the risk of developing refractory epilepsy was higher in West syndrome and in symptomatic generalized and symptomatic partial groups; it is lower in idiopathic partial and idiopathic generalized groups and intermediate in cryptogenic partial epilepsies and in epilepsies without unequivocal focal or generalized seizures. One prospective study reported similar findings. 2 Although some confidence intervals are wide, we have found some estimations of clinical relevance: the risk of refractory epilepsy at 6 years was 1% (95% CI: 0-3) in idiopathic partial epilepsies, 2% (95% CI: 0-5) in idiopathic generalized epilepsies and 9% (95% CI: 8-24) in cryptogenic partial epilepsies.
In conclusion, syndromic diagnosis and a few prognostic factors are valuable for the early prediction of refractory epilepsy in children. Both approaches are complementary. Most specific syndromes encountered in daily practice are idiopathic and they have an excellent prognosis. Most of the rest of patients are classified in non-specific categories and their prognosis may be refined using the additional prognostic factors.
